Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections

Clinical trial NCT07456826 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07456826
Sponsor: Harrow Inc
Status: ENROLLING_BY_INVITATION
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetic Macular Edema (DME)Age-Related Macular Degeneration (AMD)Retinal Vein Occlusion Diabetic Retinopathy (DR)

Start date: 2026-03-31
Primary completion: 2026-08-01
Enrollment: 236

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.